These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8305393)

  • 41. Clinical Significance of Endometrial Cells in Papanicolaou Smears of Women Attending an Organized Cervical Cancer Screening Program.
    Repše-Fokter A
    Acta Cytol; 2015; 59(4):358-9. PubMed ID: 26339795
    [No Abstract]   [Full Text] [Related]  

  • 42. A karyometric approach to the characterization of atypical endometrial hyperplasia with and without co-occurring adenocarcinoma.
    Garcia FA; Davis JR; Alberts DS; Liu Y; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 2003 Dec; 25(6):339-46. PubMed ID: 14714300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma].
    Zhou XR; Du XG
    Zhonghua Fu Chan Ke Za Zhi; 1992 Sep; 27(5):278-80, 316. PubMed ID: 1298588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histochemical characterization of endometrial proliferation using AgNOR (nucleolus organizer region)].
    Brustmann H; Riss P; Naudé S
    Gynakol Geburtshilfliche Rundsch; 1994; 34(4):220-2. PubMed ID: 7819777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant endometrial hyperplasia in patients with endometrial carcinoma.
    Gücer F; Reich O; Tamussino K; Bader AA; Pieber D; Schöll W; Haas J; Petru E
    Gynecol Oncol; 1998 Apr; 69(1):64-8. PubMed ID: 9571000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complex atypical endometrial hyperplasia in a 22-year-old woman.
    Kushwaha P; Broadbent M; Diss C; Munro JM
    J Obstet Gynaecol; 2012 Nov; 32(8):814. PubMed ID: 23075369
    [No Abstract]   [Full Text] [Related]  

  • 47. Hormones and endometrial cancer--new data from the Million Women Study.
    Brinton LA; Lacey JV; Trimble EL
    Lancet; 2005 Apr 30-May 6; 365(9470):1517-8. PubMed ID: 15866289
    [No Abstract]   [Full Text] [Related]  

  • 48. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
    Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
    Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Thin and Regular Endometrium In Endometrial Cancer - Endovaginal Ultrasound Assessment.
    Socolov D; Socolov R; Rugina V; Gabia RO; Caraueanu DM; Lupascu IA; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):604-10. PubMed ID: 30142258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endometrial cancer and hormone-replacement therapy.
    Wiegratz I; Kuhl H
    Lancet; 2005 Jul 16-22; 366(9481):201-2. PubMed ID: 16023504
    [No Abstract]   [Full Text] [Related]  

  • 52. The "red queen" and endometrial hyperplasia.
    Gambrell RD
    Fertil Steril; 1994 Feb; 61(2):401-2. PubMed ID: 8299806
    [No Abstract]   [Full Text] [Related]  

  • 53. [Early diagnosis of adenocarcinoma by endometrial cytologic samples].
    Zarcone R; D'Apuzzo N; Sansone A; Vullo G; Monarca M
    Minerva Ginecol; 1997 Sep; 49(9):421-3. PubMed ID: 9446078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hysteroscopy as a diagnostic method in postmenopausal metrorrhagia].
    Dones F; Maniscalco V; Cadili G
    Minerva Ginecol; 1992 Sep; 44(9):433-5. PubMed ID: 1436617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of estrogen-induced hyperplasia to endometrial carcinoma.
    Bhagavan BS; Parmley TH; Rosenshein NB; Jefferys JL; Grisso JA; Stolley PD
    Obstet Gynecol; 1984 Jul; 64(1):12-5. PubMed ID: 6738936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nucleolar organizer region-associated proteins and estrogen receptor of endometrial adenocarcinoma].
    Wan ZM
    Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):287-8, 315. PubMed ID: 8243149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Endometrial growth in continuous, estrogen substitution monotherapy with Estraderm TTS (0.05 mg/die) in 31 postmenopausal females].
    Meuwissen JH; van Langen H; Nielen M
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):351-4. PubMed ID: 1634098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of immunohistochemical staining for p53 expression in hyperplastic endometrium and adenocarcinoma.
    Terlikowski S; Lenczewski A; Famulski W; Sulkowska M; Dobrzycka B; Stasiuk-Barmuta A; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():195-6. PubMed ID: 11820604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.